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Modified vaccinia virus Ankara (MVA), attenuated by over 500 passages in primary chick embyro fibroblasts (CEF), is
presently being used as a safe expression vector. We compared the host ranges of MVA and the parental Ankara strain in
CEF and 15 permanent cell lines. The cells could be grouped into three categories: permissive, semipermissive, and nonpermis-
sive. For MVA, the permissive category consisted of primary CEF, a quail cell line derived from QT6, and the Syrian hamster
cell line BHK-21. Only in BHK-21 cells did the virus yield approach that occurring in primary CEF. The semipermissive category
included two African green monkey cell lines: BS-C-1 and CV-1. The nonpermissive category for MVA consisted of three
human cell lines HeLa, 293, and SW 839; one rhesus monkey cell line FRhK-4; two Chinese hamster cell lines CHO and CHL;
one pig cell line PK(15); and three rabbit cell lines RK13, RAB-9, and SIRC. The grouping for MVA with a restored K1L host
range gene was similar except for the inclusion of RK13 cells among permissive lines. The grouping for the Ankara strain,
however, was quite different with more permissive and semipermissive cell lines. Nevertheless, in cells that were permissive
for MVA, the virus replicated to higher levels than Ankara, consistent with both positive and negative growth elements
associated with the adaptation of MVA. The cell lines were also characterized according to their susceptibilty to MVA-induced
cytopathic effects, expression of a late promoter regulated reporter gene by an MVA recombinant, and stage at which virion
morphogenesis was blocked. Finally, the permissive BHK-21 cell line was shown to be competent for constructing and
propagating recombinant MVA, providing an alternative to primary CEF. q 1997 Academic Press
INTRODUCTION range genes have been described: CHOhr (Gillard et al.,
1985), C7L (Oguiura et al., 1993; Perkus et al., 1990), K1L
Modified vaccinia virus Ankara (MVA), a highly attenu- (Perkus et al., 1990), and E3L (Beattie et al., 1996; Chang
ated strain of vaccinia virus (VV), was developed as a et al., 1995). The homolog of the cowpox CHOhr gene
safe vaccine for smallpox prior to the eradication of that has been disrupted or deleted in all strains of VV and an
disease. MVA was derived from the VV Ankara strain by intact gene is required for replication of VV in Chinese
over 500 passages in primary chick embryo fibroblasts hamster ovary (CHO) cells. Expression of either CHOhr,
(CEF), after which it could no longer replicate, or repli- K1L, or C7L allows VV replication in human MRC-5 and
cated very inefficiently, in a variety of mammalian cell pig kidney PK(15) cells and either K1L or CHOhr permits
lines (Mayr et al., 1975, 1978). MVA is nonpathogenic replication in rabbit kidney RK13 cells (Perkus et al.,
in animals, including suckling and irradiated mice and 1990). The E3L gene is required for VV replication in Vero
primates (Hochstein-Mintzel et al., 1972; Mayr et al., and HeLa cells (Beattie et al., 1996; Chang et al., 1995).
1978). In addition, no serious complications were re- With the exception of the E3L gene, which codes for a
ported when MVA was administered as a smallpox vac- double-stranded RNA binding protein (Chang et al.,
cine to over 100,000 humans (Mahnel and Mayr, 1994; 1992), the functions of the host-range genes are un-
Stickl et al., 1974). In the United States, Biosafety level 2 known. An examination of the MVA genome showed that
containment and smallpox vaccination at 10-year inter- approximately 15% of the parental DNA, including most
vals have been recommended for laboratory studies with of the K1L gene, had been deleted (Altenburger et al.,
standard VV strains (Katz and Broome, 1991). MVA, how- 1989; Meyer et al., 1991). However, replacement of the
ever, was recently assigned Biosafety level 1 status with- K1L gene extended the host range of MVA only to RK13
out a vaccination requirement by the National Institutes cells. The functional status of other orthopoxvirus host
of Health intramural biosafety committee. range genes in MVA is still unknown.
The genetic basis for the host range restriction of MVA The host range restriction of MVA is unique in several
is not yet understood. At least four orthopoxvirus host- respects. First, the restriction is broader than that of other
host range mutants: efficient replication has been de-
scribed only in primary CEFs. Second, the block in non-1 Current address: Oxford BioMedica (UK) Ltd., Medawar Centre,
permissive cells occurs at a late stage of the replicationOxford Science Park, Oxford, OX4 4GA, UK.
cycle. Biochemical and electron microscopic analyses of2 To whom reprint requests should be addressed. Fax: (301) 480-
1147. E-mail: bmoss@nih.gov. HeLa cells infected with MVA indicated that viral late
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gene expression occurs but that virion morphogenesis MVA/K1L, an MVA recombinant containing a functional
K1L gene (Meyer et al., 1991), were propagated in CEFis interrupted (Sutter and Moss, 1992). In contrast, viral
protein synthesis is inhibited soon after nonpermissive cells and purified by centrifugation through a 36% su-
crose cushion (Earl et al., 1991). Virus stocks were titeredinfections with mutants of other known host range genes
(Chang et al., 1995; Gillard, 1985, Njayou et al., 1982; on CEF by immunostaining as described below. MVA
lacZ (Sutter and Moss, 1992) and WR lacZ (Carroll andRamsey-Ewing and Moss, 1995, 1996). The unimpaired
viral protein synthesis, even in nonpermissive human Moss, unpublished data) are recombinant VV derived
from MVA and WR strains, respectively. Both viruses con-cells, is an important property of MVA that accounts for
its usefulness as a safe yet efficient expression vector tain the Escherichia coli lacZ gene encoding b-galactosi-
dase (GAL) under the regulation of the VV 11K late pro-(Sutter and Moss, 1992).
Transfer plasmids for construction of stable MVA ex- moter (Bertholet et al., 1985).
pression vectors have been developed (Antoine et al.,
Immunostaining1996; Carroll and Moss, 1995; Scheiflinger et al., 1996;
Sutter and Moss, 1992; Wyatt et al., 1996) and the bacte- MVA does not form clear plaques on cell monolayers
riophage T7 RNA polymerase gene has been integrated and therefore foci were visualized by immunostaining.
into the MVA genome for transient transfection studies Briefly, cells were fixed with a 1:1 solution of metha-
(Sutter et al., 1995; Wyatt et al., 1995). Furthermore, ani- nol:acetone for 2 min, washed with phosphate buffered
mal experiments indicated that recombinant MVA pro- saline (PBS), and then incubated for 1 h at room tempera-
vided protection against challenge with influenza virus ture with rabbit polyclonal VV antiserum diluted 1:2000
(Bender et al., 1996; Sutter et al., 1994), simian immuno- with PBS containing 2% FBS. After washing twice with
deficiency virus (Hirsch et al., 1996), and parainfluenza PBS, cells were incubated for 1 h at room temperature
virus type 3 (Wyatt et al., 1996). Where comparisons were with Protein A conjugated to horseradish peroxidase
made, the immunogenicity of MVA recombinants was (HRP, Boerhinger) diluted to 1:1500 in PBS containing 2%
equal to or better than those of standard VV recombi- FBS. Cells were washed twice in PBS and incubated up
nants. In addition, MVA has been effective in a murine to 30 min with substrate solution prepared by adding 10
cancer immunotherapy model (Carroll et al., 1997). ml of 30% H2O2 and 0.2 ml of an ethanol solution saturated
As the use of MVA vectors expanded, more cell lines with dianisidine (Sigma) to 10 ml of PBS. A brown stain
were used to express recombinant proteins, and our ex- signified VV proteins. Double immunostaining, to visual-
perience and that of others indicated that the cytopathic ize recombinant protein synthesis and MVA, was done
effects (CPE) of MVA or MVA recombinants varied. In as follows: monolayers were treated as above except
some mammalian cell lines, such as BHK-21 cells, the that the 1:500 dilution of the primary antibody applied
CPE seemed comparable to those of standard VV strains was against GAL or b-glucuronidase (GUS). Protein A–
(J. K. Rose, G. Wertz, personal communications). Scien- HRP and substrate were then applied as described
tific questions pertaining to the host range of MVA, as above. GAL or GUS positive foci were enumerated and
well as practical ones concerning its use as an expres- the anti-VV sera was then used to identify all MVA foci.
sion vector, motivated us to study MVA with regard to
induction of CPE, replication, cell to cell spread, virus Virus replication
morphogenesis, and recombinant gene expression in ad-
For analysis of virus replication and spread, confluentditional mammalian and avian cell lines. For comparison,
monolayers in Costar six-well tissue culture dishes werewe also analyzed the host range properties of the paren-
infected at a multiplicity of infection (m.o.i.) of approxi-tal Ankara strain of VV and the effects of a functional K1L
mately 0.05 using a total of 5 1 104 plaque forming unitsgene on MVA host range restriction.
(PFU) in 1 ml of medium containing 2% FBS. After 45 min
at 377, cells were washed once with medium containingMATERIALS AND METHODS
2% FBS and incubated with fresh medium at 377. Cells
Cells and viruses and supernatant were harvested at 0, 24, 48, and 72 h
after absorption. For single step growth curves, cellsCell lines (Table 1) were grown under conditions sug-
were infected with an m.o.i. of 5. After freeze –thawinggested by the American Type Culture Collection (ATCC,
thrice and brief sonication, samples were assayed inRockville, MD). CEF were prepared from 10-day-old em-
duplicate on monolayers of CEF. Infected cell foci werebryos. For virus infections, CEF were used in the first
visualized by immunostaining after 24 h.passage although they are referred to as primary CEF in
the text. The quail cell line QT35 (supplied by K. Ander-
Measurement of GAL
son, USAMRIID, Frederick, MD) is a derivative of QT6
(ATCC) and was grown in E-199 medium containing 10% Cells (approximately 21 105) were infected at an m.o.i.
of 5 at 377. After 1 h, monolayers were washed with PBStryptose phosphate broth and 5% fetal bovine serum
(FBS). MVA and the parental strain VV Ankara (provided and incubated with medium containing 2% FBS. Cells
were washed and harvested in Promega reporter lysisby A. Mayr, Veterinary Faculty, University of Munich) and
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TABLE 1
Spread and Replication of MVA and Ankara after Low Multiplicity infectionsa
Virus spreadb Virus replication c
Cell ATCC
line code Species Organ Morphology MVA Ankara MVA Ankara
CEF Primary Chick embryo Assorted Fibroblast /// /// 4,200 { 200 (P) 240 { 120 (P)
QT35d CRL-1708 Quail embryo Assorted Fibroblast ND ND 69.8 { 30 (P) 12.0 { 8 (SP)
BHK-21 CCL-10 Hamster, Syrian Kidney Fibroblast /// /// 680 { 240 (P) 320 { 200 (P)
CHO CCL-61 Hamster, Chinese Ovary Epithelial 0 0 0.001 (NP) 0.001 (NP)
CHL CRL-1935 Hamster, Chinese Lung Fibroblast ND ND 0.24 (NP) 0.12 (NP)
BS-C-1 CCL-26 Monkey, African green Kidney Epithelial // /// 23.6 { 0.4 (SP) 82.0 { 38 (P)
CV-1 CCL-70 Monkey, African green Kidney Fibroblast // /// 9.60 { 2.4 (SP) 30.0 { 14 (P)
FRhK-4 CRL-1688 Monkey, Rhesus Kidney Fibroblast ND ND 0.8 (NP) 6.0 (SP)
293 CRL-1573 Human Kidney Epithelial / /// 0.03 { 0.004 (NP) 49.0 { 27 (P)
HeLa CCL-2 Human Cervix Epithelial / /// 0.07 { 0.06 (NP) 12.5 { 12 (SP)
SW 839 HTB-49 Human Kidney Fibroblast ND ND 0.003 (NP) 0.04 (NP)
PK(15) CCL-33 Pig Kidney Epithelial 0 /// 0.004 (NP) 44.0 (P)
MDCK CCL-34 Canine Kidney Epithelial ND ND 2.3 { 0.1 (SP) 106 { 18 (P)
RK13 CCL-37 Rabbit Kidney Epithelial 0 /// 0.001 (NP) 160 (P)
RAB-9 CRL-1414 Rabbit Skin Fibroblast / /// 0.98 { 0.58 (NP) 11.0 { 7 (SP)
SIRC CCL-60 Rabbit Cornea Fibroblast / /// 0.03 (NP) 136 (P)
a m.o.i. of 0.05.
b Virus spread as visualized by immunostaining after 72 h. 0, No stained cells; /, foci of 1 to 4 stained cells; //, foci of 5 to 25 stained cells;
///, foci of 25 stained cells; ND, not determined.
c Virus replication (fold increase in virus titer) determined by dividing the virus yield at 72 h by the input titer of 2.5 1 104. Letters in parentheses
refer to permissive, semipermissive, and nonpermissive for virus replication: NP, 1-fold increase; SP, 1- to 25-fold increase; P, 25-fold increase.
d QT35 cells supplied by K. Anderson were derived from QT6 cells. The ATCC code refers to QT6 cells.
buffer. GAL activity was determined using a Promega cated, and inoculated on CEF or BHK-21 cells. Recombi-
nant virus plaques expressing GAL or GUS were identi-(Madison, WI) enzyme assay kit. Standard curves were
made to determine GAL activity units. fied using the substrates X-gal (Gold BioTechnology, St.
Louis, MO) or X-glu (Clonetech Laboratories, Palo Alto,
Electron microscopic analysis CA), respectively (Carroll and Moss, 1995). After 1 h ab-
sorption, cells were overlayed with 3 ml of plaque me-Confluent cell monolayers were infected at a m.o.i. of
dium containing 2% FBS and 1% low melting point (LMP)10. The virus was allowed to adsorb for 1 h at 377 and
agarose (Gibco BRL). Cells were incubated for approxi-the cells were then washed and incubated at 377 for an
mately 40 h and overlayed with 2 ml of plaque mediumadditional 24 h. Cells were fixed in 2% glutaraldehyde
containing the relevant substrate. A blue color was evi-and processsed for transmission electron microscopy
dent within 6 to 18 h.as previously described (Wolffe et al., 1996), except that
sections were first stained with 7% uranyl acetate (Elec-
tron Microscopy Sciences, Fort Washington, PA) in 50% RESULTS
ethanol for 20 min and then with bismuth subnitrate for
Cell to cell spread of MVA and VV Ankara5 min as described (Ainsworth and Karnovsky, 1972).
As a sensitive measure of the host-range properties of
Recombinant virus construction
MVA and the parental Ankara strain of VV, we infected
primary CEF and 10 different cell lines with an m.o.i. ofMonolayers of CEF or BHK-21 cells, in six-well tissue
culture dishes, were infected with MVA at an m.o.i. of 0.01 and measured virus spread. As spread might occur
in the absence of obvious CPE, rabbit polyclonal anti-VV0.1. After 1 h at 377, cells were washed twice and over-
layed with 1 ml of Optimem (Gibco BRL). Approximately serum was used to identify cells expressing MVA proteins.
In permissive CEF, MVA produced clearly stained foci of3 mg of plasmid DNA was diluted with sterile water to
25 ml and mixed with 15 mg of lipofectin (Gibco BRL) approximately 100 cells at 24 h after infection (Fig. 1). The
stained cells maintained their spindle shape with little orpreviously diluted to a final volume of 25 ml. The DNA/
lipofectin mixture was incubated at room temperature for no evidence of CPE until several days later. Foci formed
by the parental VV Ankara strain in CEF were slightly larger,10 min and then added dropwise to the infected cells.
After a 4-h absorption, the Optimem was replaced with with gaps or holes in their centers, after 1 day (Fig. 1).
Remarkably, the viral protein staining pattern observed1 ml of medium containing 2% FBS. Cells were harvested
after an additional 40 h, frozen and thawed thrice, soni- in MVA infected Syrian baby hamster kidney BHK-21 cells
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FIG. 1. Cell-to-cell spread of MVA and VV Ankara. The indicated cells were infected with an m.o.i. of 0.01 and then fixed and immunostained
with anti-VV antibody at 24, 48, or 72 h. The panels show representative fields at approximately 2001 magnification.
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was similar to that in CEF (Fig. 1), suggesting that these
mammalian cells were able to support replication and
spread of this virus. The sizes of the foci were similar to
those seen in CEF cells and the entire monolayer showed
cytopathic effects after longer times. No other mamma-
lian cell line examined supported such extensive spread
of MVA. The greater cytopathic effects of VV Ankara,
compared to MVA, could be seen at 24 h after infection
of BHK-21 cells.
Other mammalian cell lines, exemplified by BS-C-1
(Fig. 1) and CV-1 (photograph not shown), enabled limited
spread of MVA. At 24 h, foci containing 2 to 5 cells were
frequently observed. The size of these foci steadily in-
creased to about 20 cells by 72 h (Fig. 1). To determine
if the apparent spread of MVA in BS-C-1 cells was merely
due to diffusion of MVA gene products, we specifically
inhibited virus maturation with 100 mg/ml of rifampicin
(Moss et al., 1969). After a 72-h incubation, intense immu-
nostaining occurred mainly in single cells with occa-
sional weak staining of immediately adjacent cells (data
not shown). The effect of rifampicin suggested that foci
forming in the absence of drug were due to spread of
mature infectious virions.
Several MVA inoculated cell lines, exemplified by hu-
man 293 (Fig. 1) and HeLa (photograph not shown), de-
veloped predominantly single stained cells with occa-
sional foci of less than five stained cells after a 72-h
incubation. A pattern of almost exclusively single staining
FIG. 2. Replication of MVA, MVA/K1L, and VV Ankara in selected cellcells had previously been noted with mouse L-929 cells
lines. Cells were infected with an m.o.i. of 0.05 and after adsorption(Sutter et al., 1994). Another category of cells, repre-
and 24, 48, and 72 h later, the medium and cells were harvestedsented by CHO and RK13, did not show any evidence of
together. Virus yields were determined by infecting CEF with serial
MVA protein production when immunostained (photo- dilutions and counting immunostained cell foci. The titers represent
graph not shown). Control experiments, carried out in the average values of two independent experiments, except for SW
839, PK(15), and RK13, which were done once. Standard errors arepermissive cell lines infected in the presence of the DNA
indicated by bars.replication inhibitor AraC, indicated that viral late protein
synthesis was required for detectable immunostaining.
Therefore, the block in CHO and RK13 cells occurred at
VV Ankara strain (Fig. 2). Restoration of the K1L gene,a stage before viral late gene expression. These results
however, had no significant effect on MVA replication.are consistent with the stages at which standard VV
One avian cell line tested, quail QT35, was permissivestrains lacking the CHOhr or K1L gene are blocked in
for both MVA and VV Ankara but the yields were 1 to 2CHO cells and RK13 cells, respectively (Ramsey-Ewing
logs lower than with CEF (Fig. 2).and Moss, 1995, 1996).
Three hamster cell lines were tested. The yield of MVAA summary of the data regarding MVA spread and a
in Syrian hamster BHK-21 cells was similar to that indescription of the 11 cell types examined are in Table 1.
primary CEF at 24 h, but then plateaued so that the 72-
h yield was slghtly less than in CEF (Fig. 2). The presenceReplication of MVA, MVA/K1L, and VV Ankara under
or absence of a functional K1L gene made no differencemultistep growth conditions
to MVA replication in BHK-21 cells. The yield of VV An-
kara in BHK-21 cells was slightly lower than that of MVA.The ability of VV Ankara and MVA to replicate and
The two Chinese hamster cell lines tested, CHO (Drillienspread was further investigated and quantitated in pri-
et al., 1978) and CHL (Ramsey-Ewing, personal communi-mary CEF and 15 different cell lines infected at a m.o.i.
cation), are not permissive for standard laboratory strainsof 0.05. We also examined the replication of a previously
of VV so their failure to support replication of MVA ordecribed (Meyer et al., 1991) recombinant MVA with a
MVA/K1L was predictable (Fig. 2; Table 1).restored K1L gene (referred to as MVA/K1L). At 0, 24, 48,
Three monkey cell lines were evaluated. Significantand 72 h after infection, the cells were harvested and
but low increases in MVA titers were obtained in thetitered in CEF. As previously noted (Meyer et al., 1991),
MVA replicated to a higher titer in CEF than the parental African green monkey kidney lines, BS-C-1 and CV-1 (Fig.
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2). The K1L gene did not increase the production of MVA
in these cells. However, VV Ankara grew better than MVA
in BS-C-1 and CV-1 cells. Replication of MVA was poor
in rhesus FRhK-4 kidney cells (data shown in Table 1).
In all three human cell lines tested, HeLa, 293, and
SW 839, the titers of MVA remained constant or de-
creased after the adsorption period whereas the parental
VV Ankara strain replicated (Fig.2). Here too, a functional
K1L gene was not beneficial for MVA replication.
Three rabbit cell lines were evaluated. As previously
described, MVA did not replicate in rabbit kidney (RK13)
cells, whereas both MVA/K1L and Ankara did (Fig. 2).
MVA/K1L and VV Ankara also grew better than MVA in
rabbit skin (RAB-9) cells but this cell line was inefficient
even for those strains (Fig. 2). Rabbit cornea (SIRC) cells
were permissive for Ankara but not MVA (data shown in
Table 1). K1L enhanced MVA replication in SIRC cells to
a small extent (data not shown).
The 72-h virus yields were divided by the amount of
input virus (2.5 1 104) and the ratios are listed in Table
1. Higher ratios would have been obtained if the yields
were divided by the virus titers determined after the ab-
sorption period (Fig. 2). However, that would have re-
sulted in greater variability especially as the postabsorp-
tion VV Ankara titers were usually 1 log lower than those
of either MVA or MVA/K1L, though the input titers were
similar. Cell lines were categorized using the following
criteria: nonpermissive allowing a 1-fold replication,
semipermissive allowing 1- to 25-fold replication, and FIG. 3. Synchronous infection of selected cells by MVA, MVA/K1L, and
permissive allowing 25-fold replication. These catego- VV Ankara. Cells were infected with an m.o.i. of 5 and the medium and
ries were in agreement with the more qualitative immu- cells were harvested together and the virus yields were determined as
in the legend to Fig. 2. The titers represent the average of values fromnocytological assessment of virus spread (Table 1). Two
two independent experiments. Standard errors are indicated by bars.cell lines fell into the permissive group for MVA: BHK-21
and QT35 cells. Of these, BHK-21 cells consistently gave
the higher yield. BS-C-1, CV-1 and MDCK cells were in
growth experiments are compared. We therefore deter-the semipermissive group and the others including all of
mined the virus titers following synchronous infectionsthe human cells were nonpermissive. The patterns of
at an m.o.i. of 5.permissiveness for VV Ankara and MVA were quite differ-
As expected, cells that enabled multistep growth ofent (Table 1). Thus, for VV Ankara, the BHK-21, BS-C-1,
MVA produced significant yields of virus under one-stepCV-1, 293, PK(15), MDCK, RK13, and SIRC cell lines were
growth conditions. Thus, similar high yields of MVA werepermissive; QT35, FRhK4, HeLa, and RAB-9 cell lines
obtained in primary CEF and continuous BHK-21 cellswere semipermissive; and only CHO and CHL cells were
and almost a log lower yields in QT35 cells. (Fig. 3). Onlynonpermissive. SW 839 cells also scored as nonpermis-
these three cell types produced more than 1 PFU of MVAsive, although slight replication was suggested by growth
per cell (Table 2).curves (data not shown).
Some increase in MVA titers were detected in BS-C-
1 and CV-1 cells (Fig. 3). When comparing MVA titersReplication and CPE in synchronized MVA infections
between the adsorption period and 24 h, there was a
slight increase in the human HeLa and 293 cell lines,Under the low multiplicity, multistep growth conditions
though this was at least a log lower than for VV Ankara.in the preceding section, both the formation and spread
Replication of MVA was still lower in MDCK cells; underof infectious virus were important. There are many VV
multistep conditions these cells barely scored as semi-mutants in which normal intracellular levels of infectious
permissive. Declining growth curves were seen in allvirus are formed but plaque size and cell to cell spread
other cells tested.are severely reduced (Blasco and Moss, 1991; Dallo et
Restoration of the MVA K1L gene had a markedly posi-al., 1987; Duncan and Smith, 1992; Martinez-Pomares et
tive effect only in RK13 cells. VV Ankara replicated toal., 1993). Under these circumstances, very different virus
yields are obtained when multistep and single step some extent in all cell lines except CHO and CHL. How-
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TABLE 2
Cytopathic Effects and Replication of MVA and Ankara after Synchronous Infections a
MVA MVA/K1L Ankara
CPEb CPE CPE
Cell
line 12 h 24 h PFU/cell 12 h 24 h PFU/cell 12 h 24 h PFU/cell, 24 h
CEF / /// 55.30 { 6 //// /// 43 { 4.7 /// //// 6.0 { 3.2
QT35 / /// 4.85 { 0.55 //// /// 5.50 { 0.8 //// //// 1.5 { 0.5
BHK-21 / // 59.0 { 14 / // 37 { 3.7 // /// 9.7 { 4.7
CHO / / 0.01 { 0.01 / / 0.01 { 0.01 / //// 0.01 { 0.01
CHL // /// 0.01 { 0.01 // /// 0.01 { 0.01 /// //// 0.01 { 0.01
BS-C-1 0 / 1.00 { 0.7 0 / 0.57 { 0.27 //// //// 4.6 { 3.75
CV-1 / / 0.27 { 0.07 / / 0.1 { 0.03 // //// 1.5 { 1.1
FRhK-4 //// // 0.27 { 0.07 // // 0.26 { 0.07 /// //// 0.55 { 0.45
293 /// //// 0.25 { 0.11 /// //// 0.21 { 0.08 ND //// 4.2 { 2.8
HeLa / //// 0.56 { 0.2 / //// 0.22 { 0.12 / //// 7.0 { 2
SW 839 / /// 0.17 { 0.13 / /// 0.08 { 0.07 /// //// 0.63 { 0.33
PK(15)c 0 / 0.04 { 0.02 0 / 0.02 { 0 //// // 4.17 { 0.83
MDCK ND ND 0.18 ND ND 0.01 ND ND 1.1
RK13 / //// 0.07 { 0.01 / //// 3.42 { 2.42 /// //// 7.67 { 0.67
RAB-9d 0// / 0.07 { 0.03 0// / 0.62 { 0.09 0 //// 5.45 { 3.55
SIRC ND ND 0.03 { 0 ND ND 0.08 { 0 ND ND 0.2 { 0
a m.o.i. of 5.0.
b CPE was categorized by the following criteria: no difference from control, 0; 25% CPE, /; 25 to 50% CPE, //; 50 to 75% CPE ///; 75
to 100% CPE or high level cell detachment, ////.
c CPE was / at 72 h and /// at 144 h.
d CPE was / at 72 h and //////// at 144 h.
ever, the yields were lower than MVA in CEF, QT35, and 4C, 4D). In addition, some of the immature, spherical viral
particles that formed in BS-C-1 cells contained denseBHK-21 cells and higher in the others.
In parallel with the one-step growth curves, we exam- nucleoid structures. Mature viral particles were abundant
in BS-C-1 cells infected with VV Ankara (not shown).ined the cells for CPE. Those cell lines that were permis-
sive for MVA replication generally showed CPE, although As previously reported (Sutter and Moss, 1992), the
vast majority of viral particles in MVA-infected HeLa cellsthis was delayed somewhat compared to VV Ankara (Ta-
ble 2). Some cell lines that were nonpermissive for MVA were immature. In the present study, we were able to
distinguish two types of spherical immature particles: thehad quite severe CPE by 24 h (e.g., 293, HeLa, CHL),
while with others the CPE was delayed (e.g., BS-C-1, CV- majority were typical, e.g., appearing in cross-section as
a membrane enclosing granular material; others ap-1, PK(15), and RAB-9); PK(15) and RAB-9 cells exhibited
only minor CPE even after 72 h. peared dense and were frequently associated with cis-
ternae (Fig. 4E). Some of the typical immature virions
contained nucleoids (Fig. 4F), not noted previously inVirus morphogenesis in permissive, semipermissive
MVA-infected HeLa cells (Sutter and Moss, 1992). Re-and nonpermissive cells
markably, many of the dense immature particles ap-
Sutter and Moss (1992) reported that only stages up peared to be undergoing membrane wrapping and some
to and including immature, spherical, enveloped viral par- were outside of the cell (Fig. 4F).
ticles were seen by electron microscopic examination of In RAB-9 cells infected with MVA, even immature viral
HeLa cells infected with MVA, whereas mature-looking particles were rare (not shown). Mature virions were de-
particles were abundant in CEF. We extended this analy- tected in RAB-9 cells infected with VV Ankara, but the
sis to MVA or Ankara infected CEF, BHK-21, BS-C-1, and numbers were lower than in CEF or BS-C-1 cells.
RAB-9 cells and repeated the analysis of HeLa cells.
As predicted, viral particles of all stages of maturation Late promoter regulated reporter gene expression
were evident in MVA infected BHK-21 cells (Figs. 4A, 4B)
and CEF (not shown). The viral forms were indistinguish- VV gene expression is programmed so that early
genes are expressed before DNA replication and inter-able from those of VV Ankara infected BHK-21 cells and
CEF (not shown). mediate and late ones successively afterward. As men-
tioned earlier, the ability to express late genes in nonper-Mostly immature particles were seen in MVA-infected
BS-C-1 cells, whereas mature particles were rare (Figs. missive cells is a distinguishing feature of MVA host
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FIG. 4. Electron micrographs of ultrathin sections of BHK-21 (A, B), BS-C-1 (C, D), and HeLa (E, F, G) cells infected with MVA. i, typical immature
virion; d, dense immature virion; m, brick-shaped mature virion; n, nucleoid; w, wrapping membrane. Bars, 1.0 mm.
restriction and enhances its value as an expression vec- viruses. The virus stocks had been purified by sedimenta-
tion through a 36% sucrose cushion, to remove contami-tor. We compared the expression of GAL regulated by
the same 11K late promoter in MVA and WR recombinant nating GAL produced in the permissive cell line used for
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FIG. 4—Continued
virus propagation. The highest levels of GAL were made 21 cells by either of the recombinant viruses. In BS-C-1
and CV-1 cells, the WR recombinants produced several-in CEF infected with either MVA or WR recombinant vi-
ruses (Fig. 5). The next highest levels were made in BHK- fold more GAL than the MVA recombinants. The two cell
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and 400 recombinants, respectively (Table 3). Approxi-
mately 500 recombinants were detected using the transfer
plasmid pLW22 in BHK-21 cells. The results with transfer
plasmid pMC1107GUS were similar: 200 recombinants in
CEF and 300 in BHK-21 cells. In each case, the recombi-
nant viruses were subsequently plaque purified three
times and small stocks were prepared in CEF or BHK-21
cells. All plaques, produced by these stocks, stained with
antibodies to the marker protein and to VV, confirming the
purity and stability of the recombinant viruses in both CEF
and BHK-21 cells.
DISCUSSION
VV has a remarkably broad host range and is capable
of productively infecting avian as well as mammalian
cells. In the case of MVA, repeated passaging in primary
CEF resulted in an adaptation to CEF and diminished
ability to replicate in most cell lines. Since the early pas-
sages of MVA were not preserved, we do not know
whether the same or separate mutations accounted for
the positive and negative cell-specific growth character-
istics. The present study was undertaken to document
further the host restriction of MVA and to facilitate its
use as an expression vector. In addition to primary CEF,
we infected 15 different cell lines with MVA and grouped
them as permissive, semipermissive, and nonpermissive.
Although the permissiveness of the quail cell line QT35FIG. 5. Expression of lacZ under VV late promoter control by recombi-
was not surprising in view of the avian adaptation ofnant MVA and WR. MVA and WR recombinants containing the E. coli
lacZ gene regulated by the VV 11K gene late promoter were used to MVA and the permissiveness of CEF lines (Meyer et al.,
infect cells at an m.o.i. of 5. The cells were harvested at 12, 24, and 1991; cited in Sutter and Moss, 1992), the ability of MVA
48 h after infection and lysates were tested for GAL activity. GAL units to replicate in a Syrian hamster cell line was remarkable.
per 2 1 105 cells were calculated from a standard curve. Standard
In fact, BHK-21 cells supported replication of MVA nearlyerror bars are shown.
as well as primary CEF and much better than the avian
cell lines. Moreover, MVA replicates better in BHK-21
cells than the parental VV Ankara strain, indicating thatlines that exhibited the least MVA-induced CPE, PK(15),
the adaptation to CEF carried over to BHK-21 cells. Twoand RAB-9 also produced the least GAL. Although the
African green monkey cell lines, BS-C-1 and CV-1, sup-WR recombinant virus produced reasonable amounts of
ported a low level of MVA replication, consistent with aGAL in PK(15) cells, very little was made in RAB-9 cells.
previous report of MVA replication in MA 104 cells
(Meyer et al., 1991). Nevertheless, the three human cellIsolation of recombinant MVA in BHK-21 cells
lines tested here, as well as three additional ones tested
by Meyer et al. (Meyer et al., 1991), produced 1 PFU orThe necessity of using primary CEF for the production
of recombinant MVA hinders its widespread use as a safe less of MVA per cell and were classified as nonpermis-
sive. Cells derived from a variety of other sources werealternative to fully replication competent VV strains such
as WR. In an attempt to overcome this barrier, we com- also nonpermissive for MVA. There does not appear to
be a recognizable feature that distinguishes cells thatpared the production of recombinant MVA in CEF and
BHK-21 cells using transfer plasmids that introduced for- are permissive from those that are semi- or nonpermis-
sive for MVA. Of the two permissive cell lines, one waseign genes into three different regions of the MVA genome
(Table 3). Two of the three regions were sites of deletions of avian origin and the other was Syrian hamster derived
and both were fibroblastic in morphology.that occurred during the multiple passages of MVA in CEF
(Meyer et al., 1991) and were chosen so that no additional Host range restriction could result from inhibition of
infectious virus formation or spread. Thus far, two typesviral genes would be interrupted. The third site was the
tk locus, a site that is commonly used with replication of mutations are known to prevent VV spread. One type
reduces the amount of extracellular virus (Blasco andcompetent VV strains such as WR. With transfer plasmid
pMC03, the recombination efficiencies was similar in CEF Moss, 1991; Engelstad and Smith, 1993; Rodriguez and
Smith, 1990; Wolffe et al., 1993) and the other preventsand BHK-21 cells, with the detection of approximately 200
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TABLE 3 Several aspects of this study pertain to the use of MVA
as an expression vector. One reason for choosing MVAConstruction of Recombinant MVA: Comparison between
is the high degree of attenuation and inefficient propaga-BHK-21 and CEF Cells
tion in human cells. A second reason is that MVA DNA
Recombinant MVA focib replication and gene expression are relatively unim-
Transfer Insertion paired, allowing use of strong late promoters for recombi-
vectora site CEF BHK-21
nant gene expression. However, the level of late gene
expression varied and in some cells was less than withpMC03 Deletion III 2 1 102 4 1 102
pLW22 Deletion II ND 5 1 102 replication competent strains of VV. Nevertheless, in
pMC1107Gus tk locus 2 1 102 3 1 102 cells supporting the highest recombinant gene expres-
sion, the level achieved with the MVA and WR strainsa pMC03 and pMC1107Gus both have GUS reporter genes (Carroll
were similar and in others the difference was only sev-and Moss, 1995). pLW22 has a GAL reporter gene (L. Wyatt, unpub-
eral-fold. In some situations, MVA may have been chosenlished).
b Recombinant MVA foci were identified by staining for GAL or GUS. for recombinant gene expression because of expecta-
tions of lower CPE compared to standard VV strains. This
is true for BS-C-1 and CV-1 cells. In some other cases,
however, the CPE were delayed rather than preventedthe association of actin tails with intracellular enveloped
particles (Wolffe et al., 1997). However, the correlation even in nonpermissive cells. Unfortunately, the cell lines
that were most resistant to CPE, PK(15) and RAB-9, ex-between MVA replication under multiple and single step
growth conditions in the various cell lines, indicated that pressed viral or recombinant proteins poorly. If special
cell lines are needed for specific studies, it would bethe primary block in semipermissive and nonpermissive
cell lines was formation of infectious virus. prudent to first test them with recombinant MVA to deter-
mine the extent of CPE and reporter gene expression.Electron microscopic studies confirmed the normal rep-
lication of MVA in BHK-21 cells and CEF. Both spherical BHK-21 cells can be used for constructing and propa-
gating recombinant MVA and therefore provides an alter-immature and brick-shaped mature MVA particles were
abundant in these permissive cell lines. In BS-C-1 cells, native to primary CEF. A variety of transfer plasmids that
facilitate expression cloning in the MVA genome havethere were low numbers of mature particles consistent
with the low yields of infectious virus. Some of the imma- been described (Antoine et al., 1996; Carroll and Moss,
1995; Scheiflinger et al., 1996; Sutter and Moss, 1992;ture particles had small dense nucleoids thought to con-
tain the viral DNA genome. Previous electron microscopic Wyatt et al., 1996). These plasmids allow expression of
one or two recombinant genes under moderate or strongstudies suggested that the principal defect in HeLa cells
is the failure of immature MVA particles to form condensed promoters and some provide for color screening or anti-
biotic selection of recombinant viruses. Four regions ofcores and assume the characteristic brick shape (Sutter
and Moss, 1992). In the present study, we found two types the MVA genome have been used for gene insertion:
these consist of two sites in which spontaneous dele-of immature MVA particles in HeLa cells: the majority were
similar to those observed during a normal VV infection tions had occurred during the adaptation of MVA to CEF,
the hemagglutinin region, and the tk locus. Most of ourand appeared on cross-section as a circular membrane
enclosing granular material and in some cases a nucleoid; own experience has been with recombination into the
deletion sites. Nevertheless, as reported here, we hadothers, however, were uniformly dense. The novel dense
particles were frequently associated with cisternae and no difficulty isolating a tk0 recombinant MVA with either
CEF or BHK-21 cells, suggesting that the many transfersome were undergoing wrapping by cellular membranes.
Wrapped dense particles were even found in extracellular plasmids previously constructed for use with standard
strains of VV (Earl and Moss, 1991) may be suitable forspaces, suggesting that they had passed through the
plasma membrane. It will be interesting to determine the MVA. However, we may have been fortunate in this one
case since Scheiflinger et al. (1996) reported that tk0biochemical and enzymatic composition of these particles
and to evaluate whether they might be responsible for the MVA recombinants were difficult to purify in CEF, leading
them to include a functional fowlpox virus tk gene in theirspread of MVA to immediately adjacent HeLa cells as
revealed by immunostaining. Some nonpermissive lines transfer plasmids. Whether BHK-21 cells are superior to
CEF for tk0 MVA remains to be determined.such as RAB-9, have an earlier block which prevented
accumulation of significant numbers of immature enve- Recent marker rescue experiments in our laboratory
indicate that the MVA phenotype is the result of multipleloped virions. Reporter or viral gene expression studies
suggested that the defect in RAB-9, PK(15), and RK13 cells gene defects that have an additive effect on host restric-
tion (M. Carroll, C. Czerny, and B. Moss). This is an excel-involves inhibition of viral late protein synthesis. In the
latter case, the defect was due to the absence of a func- lent result with regard to the safety of recombinant MVA,
since spontaneous revertants are most unlikely. How-tional K1L gene. The host restriction in CHO cells probably
involves the absence of a functional CHOhr gene although ever, this result will surely complicate our efforts to un-
derstand the basis of MVA host restriction.this was not specifically examined.
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